This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Tobacco  • Pulmonary Diseases, Other  • Women's Health, Other  • Oncology  • Lung Cancer  • Alert me on articles by topic

Gender Equality at a Crossroad?

Alfred I. Neugut, MD, PhD; Judith S. Jacobson, DrPH, MBA

JAMA. 2006;296:218-219.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Ever since the American Cancer Society began reporting incidence and mortality data on specific cancers, lung cancer has stood out as a predominantly male disease.¹ However, since World War II, when cigarette smoking became socially acceptable for and marketed to women, their lung cancer incidence rates have risen. Gender equality in lung cancer incidence rates may be attained in the near future.²

Until recently, women had lower incidence of and mortality rates from lung cancer than men, either because women did not smoke or started smoking at a later age than men. Male and female smokers differ in the histological types of lung cancer with which they are diagnosed; women are more likely than men to develop adenocarcinoma. This difference in histology has been attributed to differences in the tar content of the cigarettes men and women smoke and in . . . [Full Text of this Article]

Author Affiliations: Department of Medicine and Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY (Drs Neugut and Jacobson).

RELATED ARTICLE

Women's Susceptibility to Tobacco Carcinogens and Survival After Diagnosis of Lung Cancer
International Early Lung Cancer Action Program Investigators
JAMA. 2006;296(2):180-184.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Update in Lung Cancer 2006
Dubey and Powell
Am. J. Respir. Crit. Care Med. 2007;175:868-874.
FULL TEXT  

The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer
Weiss et al.
Ann Oncol 2007;18:453-460.
ABSTRACT | FULL TEXT  

In Reply
Giacchetti et al.
JCO 2007;25:606-607.
FULL TEXT